Coissac Patrice 4
4 · ALEXION PHARMACEUTICALS INC · Filed Nov 18, 2011
Insider Transaction Report
Form 4
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2011-11-16−32,766→ 67,234 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (32,766 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2011-11-16$22.90/sh+32,766$750,341→ 150,648 total - Sale
Common Stock, par value $.0001 per share
2011-11-16$66.87/sh−72,766$4,865,862→ 77,882 total - Exercise/Conversion
Option to Purchase Common Stock
2011-11-16−40,000→ 0 totalExercise: $11.92From: 2007-10-11Exp: 2017-07-11→ Common Stock, par value $.0001 per share (40,000 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2011-11-16$11.92/sh+40,000$476,800→ 117,882 total
Footnotes (2)
- [F1]Reporting person's ownership reflects the 2-for-1 common stock split effected by Alexion in the form of a dividend on May 20, 2011.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $66.45 - $67.32. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.